The following income statement items appeared on the adjusted trial balance of Schembri Manufacturing Corporation for the year

ended December $31,2024($ $ in thousands$)$: sales revenue, $$18,100$; cost of goods sold, $$7,600$; selling expenses, $$1,440$; general and

administrative expenses, $$940$; interest revenue, $$200$; interest expense, $$300.$ Income taxes have not yet been recorded. The

company's income tax rate is $25\%$ on all items of income or loss. These revenue and expense items appear in the company's income

statement every year. The company's controller, however, has asked for your help in determining the appropriate treatment of the

following nonrecurring transactions that also occurred during $2024($$ in thousands$).$ All transactions are material in amount.

Investments were sold during the year at a loss of $$360.$ Schembri also had an unrealized gain of $$500$ for the year on

investments in debt securities that qualify as components of comprehensive income.

One of the company's factories was closed during the year. Restructuring costs incurred were $$1,700.$

During the year, Schembri completed the sale of one of its operating divisions that qualifies as a component of the entity

according to GAAP. The division had incurred a loss from operations of $$700$ in $2024$ prior to the sale, and its assets were sold at

a gain of $$1,680.$

In $2024,$ the company's accountant discovered that depreciation expense in $2023$ for the office building was understated by

$$340.$ The amount is considered material.

Negative foreign currency translation adjustment for the year totaled $$400.$

Required:

Prepare Schembri's single, continuous multiple$-$step statement of comprehensive income for $2024,$ including earnings per share

disclosures. There were $1,000,000$ shares of common stock outstanding at the beginning of the year and an additional $400,000$

shares were issued on July $1,2024.$

Prepare a separate statement of comprehensive income for $2024.$